Glandular Tissue Component on Breast Ultrasound in Dense Breasts: A New Imaging Biomarker for Breast Cancer Risk

References

1. Weaver O, Leung JWT. Biomarkers and imaging of breast cancer. AJR Am J Roentgenol 2018;210:271-278
2. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227-236
3. Butler RS, Hooley RJ. Screening breast ultrasound: update after 10 years of breast density notification laws. AJR Am J Roentgenol 2020;214:1424-1435
4. Berg WA, Rafferty EA, Friedewald SM, Hruska CB, Rahbar H. Screening algorithms in dense breasts: AJR expert panel narrative review. AJR Am J Roentgenol 2021;216:275-294
5. Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet 2016;387:341-348
6. Comstock CE, Gatsonis C, Newstead GM, Snyder BS, Gareen IF, Bergin JT, et al. Comparison of abbreviated breast MRI vs digital breast tomosynthesis for breast cancer detection among women with dense breasts undergoing screening. JAMA 2020;323:746-756
7. Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, et al. Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med 2019;381:2091-2102
8. Cho N, Han W, Han BK, Bae MS, Ko ES, Nam SJ, et al. Breast cancer screening with mammography plus ultrasonography or magnetic resonance imaging in women 50 years or younger at diagnosis and treated with breast conservation therapy. JAMA Oncol 2017;3:1495-1502
9. Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, et al. Supplemental screening for breast cancer in women with dense breasts: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2016;164:268-278
10. Sprague BL, Gangnon RE, Burt V, Trentham-Dietz A, Hampton JM, Wellman RD, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst 2014;106:dju255
11. Hong S, Song SY, Park B, Suh M, Choi KS, Jung SE, et al. Effect of digital mammography for breast cancer screening: a comparative study of more than 8 million Korean women. Radiology 2020;294:247-255
12. Kerlikowske K, Sprague BL, Tosteson ANA, Wernli KJ, Rauscher GH, Johnson D, et al. Strategies to identify women at high risk of advanced breast cancer during routine screening for discussion of supplemental imaging. JAMA Intern Med 2019;179:1230-1239
13. Singletary SE. Rating the risk factors for breast cancer. Ann Surg 2003;237:474-482
14. Kuhl CK. Predict, then act: moving toward tailored prevention. J Clin Oncol 2019;37:943-945
15. Mendelson EB, Bohm-Velez M, Berg WA, Whitman GJ, Feldman MI, Madjar H, et al. ACR BI-RADS ultrasound. In: Orsi CJ, Sickles EA, Mendelson EB, Morris EA, eds. ACR BI-RADS Atlas, breast imaging reporting and data system, 5th ed. Reston: American College of Radiology, 2013:128-130
16. Izumori A, Horii R, Akiyama F, Iwase T. Proposal of a novel method for observing the breast by high-resolution ultrasound imaging: understanding the normal breast structure and its application in an observational method for detecting deviations. Breast Cancer 2013;20:83-91
17. Stavros AT. Breast ultrasound. Philadelphia: Lippincott Williams & Wilkins, 2004:65-78
18. McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA, et al. Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol 2009;27:5893-5898
19. Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, et al. Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol 2010;28:2207-2212
20. Kim WH, Lee SH, Chang JM, Cho N, Moon WK. Background echotexture classification in breast ultrasound: inter-observer agreement study. Acta Radiol 2017;58:1427-1433
21. Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, et al. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol 2020;17:687-705
22. Kerlikowske K, Grady D, Barclay J, Frankel SD, Ominsky SH, Sickles EA, et al. Variability and accuracy in mammographic interpretation using the American College of Radiology breast imaging reporting and data system. J Natl Cancer Inst 1998;90:1801-1809
23. Berg WA, Blume JD, Cormack JB, Mendelson EB. Operator dependence of physician-performed whole-breast US: lesion detection and characterization. Radiology 2006;241:355-365
24. Melsaether A, McDermott M, Gupta D, Pysarenko K, Shaylor SD, Moy L. Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training. AJR Am J Roentgenol 2014;203:209-215
25. Lee SH, Ryu HS, Jang MJ, Yi A, Ha SM, Kim SY, et al. Glandular tissue component and breast cancer risk in mammographically dense breasts at screening breast US. Radiology 2021;301:57-65
26. Kim WH, Moon WK, Kim SJ, Yi A, Yun BL, Cho N, et al. Ultrasonographic assessment of breast density. Breast Cancer Res Treat 2013;138:851-859
27. Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, et al. Population-based assessment of the association between magnetic resonance imaging background parenchymal enhancement and future primary breast cancer risk. J Clin Oncol 2019;37:954-963
28. Kim SH, Kim HH, Moon WK. Automated breast ultrasound screening for dense breasts. Korean J Radiol 2020;21:15-24
29. Chang RF, Hou YL, Lo CM, Huang CS, Chen JH, Kim WH, et al. Quantitative analysis of breast echotexture patterns in automated breast ultrasound images. Med Phys 2015;42:4566-4578
30. Yala A, Mikhael PG, Lehman C, Lin G, Strand F, Wan YL, et al. Optimizing risk-based breast cancer screening policies with reinforcement learning. Nat Med 2022;28:136-143